/KASE, December 8, 2017/ - Chimpharm (Shymkent), whose shares are officially listed on Kazakhstan Stock Exchange (KASE), has in an official letter informed KASE of concluding a major transaction.

Said information is available on KASE website (in Kazakh and Russian) - see more

[2017-12-08]